This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Anjaneya Aravind Kumar Kolluru: Innovator in Anticancer Research
Introduction
Anjaneya Aravind Kumar Kolluru is a notable inventor based in Jammu, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with potential anticancer properties. His work focuses on innovative approaches to inhibit specific enzymes that play a crucial role in cancer progression.
Latest Patents
Kolluru holds a patent for "Boronic acid bearing liphagane compounds as inhibitors of P13K-α and/or β." This invention describes unique liphagane meroterpenoid scaffolds that incorporate boronic acid functionality. The patent outlines the pharmacological potential of these compounds as anticancer agents. It also presents a method for preparing these compounds and inhibiting the activity of phosphoinositide-3-kinase (PI3K-alpha and beta). The invention emphasizes the novel structures based on the liphagane scaffold, which exhibit unique boronic acid functionality.
Career Highlights
Anjaneya Aravind Kumar Kolluru is affiliated with the Council of Scientific and Industrial Research, where he conducts research aimed at developing innovative therapeutic agents. His work has garnered attention for its potential impact on cancer treatment, showcasing his commitment to advancing medical science.
Collaborations
Kolluru has collaborated with esteemed colleagues, including Sanghapal Damodhar Sawant and Ajit Kumar Saxena. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Anjaneya Aravind Kumar Kolluru is a pioneering inventor whose work in developing boronic acid bearing liphagane compounds holds promise for future cancer therapies. His contributions to medicinal chemistry reflect a dedication to improving health outcomes through innovative research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
